Search by Drug Name or NDC

    NDC 61703-0408-25 Methotrexate 25 mg/mL Details

    Methotrexate 25 mg/mL

    Methotrexate is a INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is METHOTREXATE SODIUM.

    Product Information

    NDC 61703-0408
    Product ID 61703-408_a70fd689-9446-44cc-bd40-77c997b50258
    Associated GPIs 21300050102075
    GCN Sequence Number 051610
    GCN Sequence Number Description methotrexate sodium/PF VIAL 25 MG/ML INJECTION
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 18936
    HICL Sequence Number 024819
    HICL Sequence Number Description METHOTREXATE SODIUM/PF
    Brand/Generic Generic
    Proprietary Name Methotrexate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methotrexate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 25
    Active Ingredient Units mg/mL
    Substance Name METHOTREXATE SODIUM
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA011719
    Listing Certified Through 2025-12-31

    Package

    NDC 61703-0408-25 (61703040825)

    NDC Package Code 61703-408-25
    Billing NDC 61703040825
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-408-25) / 40 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2013-11-11
    NDC Exclude Flag N
    Pricing Information N/A